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Abstract
Background: B-type natriuretic peptide (BNP) is increased in post-cardiac surgery patients,
however the mechanisms underlying BNP release are still unclear. In the current study, we aimed
to assess the relationship between postoperative BNP levels and left ventricular filling pressures in
post-cardiac surgery patients.
Methods: We prospectively enrolled 134 consecutive patients referred to our Center 8 ± 5 days
after cardiac surgery. BNP was sampled at hospital admission and related to the following
echocardiographic parameters: left ventricular (LV) diastolic volume (DV), LV systolic volume (SV),
LV ejection fraction (EF), LV mass, relative wall thickness (RWT), indexed left atrial volume (iLAV),
mitral inflow E/A ratio, mitral E wave deceleration time (DT), ratio of the transmitral E wave to the
Doppler tissue early mitral annulus velocity (E/E').
Results: A total of 124 patients had both BNP and echocardiographic data. The BNP values were
significantly elevated (mean 353 ± 356 pg/ml), with normal value in only 17 patients (13.7%). Mean
LVEF was 59 ± 10% (LVEF ≥50% in 108 pts). There was no relationship between BNP and LVEF (p
= 0.11), LVDV (p = 0.88), LVSV (p = 0.50), E/A (p = 0.77), DT (p = 0.33) or RWT (p = 0.50). In
contrast, BNP was directly related to E/E' (p < 0.001), LV mass (p = 0.006) and iLAV (p = 0.026).
At multivariable regression analysis, age and E/E' were the only independent predictors of BNP
levels.
Conclusion: In post-cardiac surgery patients with overall preserved LV systolic function, the
significant increase in BNP levels is related to E/E', an echocardiographic parameter of elevated LV
filling pressures which indicates left atrial pressure as a major determinant in BNP release in this
clinical setting.
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Background
B-type natriuretic peptide (BNP), a cardiac hormone syn-
thesized by ventricular myocytes in response to left ven-
tricular (LV) dysfunction and wall stress, has been shown
to be increased in patients with cardiovascular disease
such as heart failure,[1] cardiac hypertrophy,[2] and acute
coronary syndromes [3]. Although in most of these situa-
tions the increase in BNP is related to systolic LV dysfunc-
tion [4], recent evidences suggest that, at least in patients
with heart failure, elevated LV filling pressures may also
act as a trigger for BNP release [5,6] and are likely to
reduce exercise capacity [7]. More recently, high levels of
BNP have also been reported early after cardiac surgery,
with prognostic implications for prolonged hospital stay
and 1-year mortality [8]. However, it is worth noting that
in post-cardiac surgery patients, as compared to patients
with heart failure, LV ejection fraction does not correlate
as much as expected with BNP levels [9]. Thus, in this clin-
ical setting, factors other than LV systolic function, such as
myocardial damage during aortic cross clamping, have
been advocated;[10] however the results of these studies
are still controversial and the mechanisms underlying
BNP release remain unclear.
We hypothesized that elevated LV filling pressures in post-
cardiac surgery patients may account for the increase in
plasma BNP. Thus, we designed this prospective study
with the aims of assessing the relationship between post-
operative BNP levels and LV filling pressures as evaluated
by transthoracic two-dimensional and Doppler echocar-
diography.
Methods
We prospectively enrolled 134 consecutive in-hospital
patients admitted to our Centre for a cardiac rehabilita-
tion program 8 ± 5 days after a cardiac surgery procedure.
No patients required urgent cardiac surgery due to acute
myocardial infarction or acute heart failure. Patients in
haemodialysis were excluded. All patients were clinically
stable and followed the medical therapy prescribed by the
referring physicians.
Participants in the study had complete data on age, sex,
diabetes mellitus (glucose level >126 mg/dl or hypogli-
cemic drugs), renal insufficiency (serum creatinine value
≥1.5 mg/dl), type of cardiac surgery, and length of hospi-
talization. The investigation conforms with the principles
outlined in the Declaration of Helsinki. The hospital insti-
tutional review board approved the study and written
informed consent to participate in the study was obtained
from all patients.
BNP measurements
Blood samples (5 ml) were obtained 24 hours after
patient admission. In all patients, blood was sampled
from an antecubital vein after 15 minutes of supine rest
and collected into a sampling tube containing potassium
EDTA. Samples were analyzed for BNP levels using a
microparticle enzyme immunoassay (Abbott Laborato-
ries, Abbott Park, Illinois, USA). The precision and sensi-
tivity of this kit have been previously described by Rawlins
et al [11].
Echocardiography
All the patients underwent a comprehensive echocardio-
graphic study within 24 hours after admission at our
Center using a commercially available ultrasound equip-
ment (Philips Sonos 5500, Andover, Massachusetts,
USA). All measurements were made according to the rec-
ommendations of the American Society of Echocardiogra-
phy/European Association of Echocardiography [12].
The left ventricular (LV) assessment included measure-
ment of the diastolic (DV) and systolic (SV) volumes with
derived ejection fraction (LVEF) using the modified
biplane Simpson's method, mass, and relative wall thick-
ness (RWT). Left atrial volume was derived using the mod-
ified biplane Simpson's method and the value was
indexed by body surface area. Mitral inflow was assessed
from the apical 4-chamber view using pulsed-wave Dop-
pler. Early-to-late diastolic velocities (E/A) ratio was calcu-
lated, as well as the deceleration time (DT) of the E wave.
The early diastolic velocities at the septal and lateral mitral
annulus were obtained from the apical 4-chamber view
using Doppler tissue imaging, and the values were aver-
aged (E'). LV filling pressure was estimated by the E/E'
ratio [13].
Statistics
All analyses were performed by using SPSS for Windows
(version 12.0.1, Chicago Ill.). Continuous variables are
expressed as mean ± SD. Categorical variables are
expressed as number of subjects and percentages. Since
plasma concentrations of BNP did not follow a Gaussian
distribution, the values were log-transformed before sta-
tistical analysis. We used the independent Student's t test
for univariate comparison of log-transformed BNP
[ln(BNP)] value within dichotomic variables. Correla-
tions between continuous variables were tested by Pear-
son's correlation test. Multiple regression analysis was
used to clarify the contribution of each independent vari-
able to BNP having ln(BNP) as the dependent variable.
Statistical significance was assumed at p < 0.05.
Results
Ten patients were excluded because of poor acoustic win-
dows that resulted in incomplete echocardiographic
measurements. Thus, a total of 124 patients with BNP and
echocardiographic data formed the final group and were
included in the analysis (Table 1).Cardiovascular Ultrasound 2009, 7:49 http://www.cardiovascularultrasound.com/content/7/1/49
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BNP after cardiac surgery
Plasma BNP levels were significantly elevated in the study
group (range 39-2808 pg/ml; mean 353 ± 346 pg/ml) and
only 17 (13.7%) patients had normal BNP levels (<100
pg/ml). After log-transformed, the mean ln(BNP) was
5.54 ± 0.8 (range 3.66-7.94). The mean value of BNP was
significantly higher for women compared to men, while
no differences were found according to the presence of
diabetes mellitus, renal failure, or coronary artery bypass
graft (see Table 2). There was a mild but significant asso-
ciation between BNP and patient's age (Pearson's coeffi-
cient = 0.302, p < 0.001), while length of hospital stay was
not associated with BNP (Pearson's coefficient = -0.99, p
= 0.273).
BNP and echocardiographic parameters
The mean LVEF was 59 ± 10%; 108 patients (87%) had a
LVEF ≥50%. Mean ln(BNP) levels and E/E' were similar in
patients with LVEF≥50% compared to patients with
LVEF<50% (Table 3). The echocardiographic parameters
of the study group are presented in Table 4. There was no
correlation between ln(BNP) and LV volumes, LVEF,
RWT, E/A, DT. The relationship between ln(BNP) and E/
E' values is depicted in Figure 1, showing that BNP is
directly related to LV filling pressure (Pearson's coeffi-
cient: 0.36, p < 0.001). Overall, patients with low BNP lev-
els had low values of E/E' ratio [see Additional file 1],
while patients with high BNP levels had the highest E/E'
ratios [see Additional file 2]. A similar correlation was
Table 1: Clinical characteristics of the study population.
Number of patients 124
Male, nr (%) 83 (67)
Age, mean ± SD (yrs) 67 ± 10
Days after cardiac surgery, mean ± SD 8 ± 5
Type of surgery, nr (%)
- CABG 67 (54)
- Valve surgery 39 (31)
- CABG + valve surgery 11 (9)
- Aorta replacement 7 (6)
Renal failure, nr (%) 18 (14)
Diabetes, nr (%) 30 (24)
Medical therapy, nr (%)
- betablockers 72 (61)
- ACE-inhibitors 81 (78)
- ARB 15 (13)
- Diuretics 92 (78)
ACE = angiotensin converting enzyme; ARB = angiotensin receptor 
blockers; CABG = coronary artery bypass graft.
Table 2: Mean value of ln(BNP) according to female gender, 
presence of renal failure, diabetes mellitus, and coronary artery 
by-pass surgery (CABG).
N (%) Mean (SD) p value
Female gender 41 (33) 5.76 (0.80)
0.032
Male gender 83 (67) 5.44 (0.79)
Diabetes mellitus, yes 30 (24) 5.71 (0.77)
0.197
Diabetes mellitus, no 94 (76) 5.49 (0.81)
Renal failure, yes 18 (15) 5.71 (0.96)
0.358
Renal failure, no 106 (85) 5.52 (0.78)
CABG 67 (54) 5.61 (0.84)
0.312
Other cardiac surgery 57 (46) 5.47 (0.76)
Total 124 (100) 5.55 (0.80)Cardiovascular Ultrasound 2009, 7:49 http://www.cardiovascularultrasound.com/content/7/1/49
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found between ln(BNP) and LV mass (Pearson's coeffi-
cient 0.25, p = 0.006) (Figure 2), and, albeit weaker,
between ln(BNP) and iLAV (Pearson's coefficient 0.2, p =
0.026) (Figure 3). However, when entered into a multiple
regression model, age and E/E' remained the only inde-
pendent predictors of BNP levels (Table 5).
Discussion
Elevated BNP levels have been previously reported both
prior to and immediately after cardiac surgery. Such find-
ings have been associated with cardiac complications,
prolonged hospital stay, and 1-year mortality [8,14,15].
However, the reasons for BNP increase in this clinical set-
ting have not been clarified yet, with BNP inconsistently
associated with a variety of factors related to surgery, such
as biomarkers of myocardial damage, anaesthesia, ster-
notomy, etc [16]. Since BNP increase reflects hemody-
namic changes, we believe that the ultimate reason for
BNP increase in these patients could be the loading
changes that occur during and after cardiac surgery. Thus,
we hypothesized that elevated LV filling pressures might
be the trigger for BNP release.
The main findings of the present study can be summa-
rized as follows:
1. the vast majority of post-cardiac surgery patients
show a significant increase in BNP levels;
2. the increase in BNP levels does not correlate with LV
systolic function;
3. E/E' ratio, an echocardiographic marker of filling
pressures, is strongly associated with elevated BNP lev-
els.
BNP and ventricular function
In patients with heart failure, plasma BNP levels are
inversely related to LV systolic function [17]. In contrast,
in our study population we did not find any correlation
between BNP levels and systolic LV function as evaluated
by echocardiographic ejection fraction. This finding is not
surprising, since in the study group, which represents con-
secutive patients admitted to our Center, the prevalence of
LV systolic dysfunction is rather low (only 3 patients had
a LVEF <40%). Although our population was not selected,
this might not represent the whole spectrum of post car-
diac surgery patients.
Table 3: Mean value of ln(BNP) and E/E' according to the 
presence or absence of left ventricular systolic dysfunction.
LVEF <50% LVEF ≥50%
(n = 16) (n = 108)
Ln(BNP) 5.4 ± 0.5 5.5 ± 0.8 n.s.
E/E' 9.6 ± 3.7 9.4 ± 2.9 n.s.
Table 4: Echocardiographic parameters in the study group.
Parameter Mean ± SD Pearson's coefficient p value
LVDV (ml) 80.4 ± 32.3 0.015 0.883
LVSV (ml) 34.8 ± 21.3 0.070 0.507
LVEF (%) 59 ± 10 -0.15 0.11
LV mass (g/m2.7) 57.3 ± 18.3 0.25 0.006
RWT 0.48 ± 0.10 0.061 0.50
iLA volume (ml/m2) 31.2 ± 10.7 0.2 = 0.026
E/A 1.06 ± 0.34 -0.028 0.772
DT (msec) 203 ± 52 0.093 0.336
E/E' 9.48 ± 3.07 0.36 <0.001Cardiovascular Ultrasound 2009, 7:49 http://www.cardiovascularultrasound.com/content/7/1/49
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More recently, in patients with heart failure, an increase in
BNP levels has also been related to diastolic (dys)function
[4,18]. To this aim, most studies have used conventional
echocardiographic parameters, such as mitral inflow
diastolic velocities. However, in patients with preserved
LV systolic function, i.e. the vast majority of those
included in our study, the diagnostic value of these
parameters is rather limited and newer echocardiographic
modalities are warranted for a comprehensive categoriza-
tion of the patient's hemodynamic profile. Doppler myo-
cardial velocities at the mitral annulus are widely used for
a (relatively) load-independent evaluation of diastolic
properties, and left atrial volume is increasingly consid-
ered as a long-term biomarker of average LV diastolic pres-
sure [19].
Table 5: Multivariable linear regression for ln(BNP) as dependent variable (covariates: E/E', age, LV mass, LVEF, iLAV, gender).
Variable Regression coefficient 95% CI Standardized coefficient p value
E/E' 0.068 0.016-0.119 0.256 0.011
Age, yrs 0.018 0.003-0.032 0.2220 0.015
LV mass 0.006 -0.001-0.014 0.147 0.101
LVEF -0.011 -0.025-0.003 -0.025 0.134
iLAV 0.003 -0.005-0.011 0.075 0.410
Gender -0.012 -0.330-0.306 0.007 0.941
Model R2 = 0.222 <0.001
Correlation analysis of ln(BNP) vs E/E' ratio Figure 1
Correlation analysis of ln(BNP) vs E/E' ratio. Circles 
represent individual values of brain natriuretic peptide. The 
black line represents the linear regression curve fit and the 
dotted lines its 95% confidence interval.
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Correlation analysis of ln(BNP) vs left ventricular (LV) mass Figure 2
Correlation analysis of ln(BNP) vs left ventricular 
(LV) mass. Circles represent individual values of brain natri-
uretic peptide. The black line represents the linear regression 
curve fit and the dotted lines its 95% confidence interval.
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BNP and newer echocardiographic parameters of diastolic 
dysfunction
E/E' ratio as an index of LV filling pressures
Several studies have evaluated the relationship between
BNP levels and the E/E' ratio in different clinical settings
(ambulatory patients,[20] heart failure[21]), with consist-
ent results that demonstrate a relationship between BNP
levels and echocardiographic indices of LV filling pres-
sures. The findings of the present study obtained in post-
cardiac surgery patients are in line with those from previ-
ous reports in different clinical settings: we observed a sig-
nificant correlation between BNP levels and the E/E' ratio,
indicating elevated filling pressures as the major determi-
nant of BNP release.
Left atrium as an index of chronic diastolic dysfunction
During diastole, the left atrium is directly exposed to LV
pressures. Abnormal LV diastolic function causes an eleva-
tion of filling pressures, which may lead to left atrial dila-
tation over time. In the present study, iLAV is associated
with BNP values, however when entered into a multivari-
able regression analysis this parameter did not retain its
statistical power as predictor of BNP levels.
Additional factors affecting BNP levels
Age, female gender, and renal failure are all variables
related to BNP levels [22,23]. In our study, a statistically
significant direct relationship between BNP levels and
patient age was observed. In contrast, the difference in
BNP values according to renal function, although present,
was not significant perhaps because of the small sample
size of our study population and the exclusion of patients
on haemodialysis.
Study limitations
There are several limitations of our study. First, BNP levels
before cardiac surgery were not sampled. Thus, we cannot
exclude that at least in some patients BNP levels had been
elevated before surgery. Secondly, we did not perform any
invasive hemodynamic tests to evaluate the relationship
between hemodynamic status and BNP levels. Previous
studies have already shown a close correlation between
BNP levels and LV end-diastolic pressure. Thirdly, we did
not evaluate the impact of cardioplegic arrest on BNP lev-
els. Finally, follow-up data that may show if elevated BNP
levels are associated with worse clinical outcome are lack-
ing. Although length in-hospital stay was independent
from BNP levels, the potential role of BNP levels for long-
term prognostication of post cardiac surgery patients
remains to be assessed.
Conclusion
What is, then, the clinical relevance of this study? We
believe that early after cardiac surgery an increase in LV
filling pressure is very likely to occur, independent from
LV systolic function, and is a trigger for a significant BNP
release. In this clinical setting Doppler echocardiogram is
a good alternative to BNP samples for assessing LV filling
pressures, and E/E' in particular is a practical and more
convenient parameter for detecting and monitoring
haemodynamic imbalance.
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Correlation analysis of ln(BNP) vs indexed left atrial volume  (iLAV) Figure 3
Correlation analysis of ln(BNP) vs indexed left atrial 
volume (iLAV). Circles represent individual values of brain 
natriuretic peptide. The black line represents the linear 
regression curve fit and the dotted lines its 95% confidence 
interval.
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Additional file 1
Echocardiographic data of a patient with normal BNP. The data pro-
vided represent two-dimensional images and Doppler samples of a 65-year 
old man after coronary artery bypass graft. In this patient, E/E' was 5.7, 
consistent with normal LV filling pressures, and BNP levels were normal 
(64 pg/ml).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-49-S1.pdf]
Additional file 2
Echocardiographic data of a patient with high BNP. The data provided 
represent two-dimensional images and Doppler samples of a 64-year old 
man after surgery for ascending aorta aneurysm. In this case, E/E' was 
16.4, suggesting elevated LV filling pressures, and BNP levels were signif-
icantly elevated (855 pg/ml).
Click here for file
[http://www.biomedcentral.com/content/supplementary/1476-
7120-7-49-S2.pdf]